ARS Pharmaceuticals, Inc. Common Stock Share Price
NASDAQ: SPRYHealthcare
Live ARS Pharmaceuticals, Inc. Common Stock Share Price Chart
O H L
ARS Pharmaceuticals, Inc. Common Stock Performance Overview
Days Range
▼
$4.11Low
$4.14High
Markets Today
| Previous Close | $4.15 |
|---|---|
| Open | $4.14 |
| Volume | 159,652 |
| Day's Range | $4.11 - $4.14 |
| 52W Range | $4.13 - $13.15 |
| Market Cap | $414.20 M |
Historical Performance
| 1M Returns | -34.13 |
|---|---|
| 3M Returns | -56.99 |
| 6M Returns | -50.00 |
| 1Y Returns | -58.21 |
| 5Y Returns | NA |
| 10Y Returns | NA |
ARS Pharmaceuticals, Inc. Common Stock Fundamentals
| Market Cap | $414.20 M |
|---|---|
| Dividend yield | 0.00 |
| PE Ratio | 0.00 |
| PEG Ratio | N/A |
| Revenue | $84.28 M |
| ROE TTM | -0.92 |
| EPS TTM | $-2.17 |
| Quarterly Earnings Growth YOY | N/A |
| PB Ratio | 33.10 |
| EBITDA | $-178.08 M |
| Profit Margin | -203.25 |
| Market Cap | $414.20 M |
|---|---|
| Dividend yield | 0.00 |
| PE Ratio | 0.00 |
| PEG Ratio | N/A |
| Revenue | $84.28 M |
| ROE TTM | -0.92 |
| EPS TTM | $-2.17 |
|---|---|
| Quarterly Earnings Growth YOY | N/A |
| PB Ratio | 33.10 |
| EBITDA | $-178.08 M |
| Profit Margin | -203.25 |
ARS Pharmaceuticals, Inc. Common Stock Profit & Loss
Quarterly
| Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|
| Total Revenue + | $7.97 M | $15.72 M | $32.50 M | $28.09 M | $22.68 M | $33.66 M |
| Gross Profit + | $6.88 M | $10.73 M | $24.31 M | $21.93 M | $16.39 M | $20.81 M |
| Operating Income | -$37.18 M | -$47.61 M | -$53.19 M | -$41.47 M | -$60.15 M | -$61.47 M |
| EBITDA | -$36.90 M | -$47.34 M | -$52.80 M | -$41.05 M | -$59.75 M | -$61.05 M |
| Interest Expense | $0 | $0 | $0 | $0 | $0 | -$2.48 M |
| Depreciation | $280.00 K | $279.00 K | $391.00 K | $417.00 K | $397.00 K | $416.00 K |
| Income Before Tax | -$33.94 M | -$44.88 M | -$51.11 M | -$41.18 M | -$60.62 M | -$62.34 M |
| Income Tax Expense | $0 | $0 | $0 | -$80.00 K | $0 | $0 |
| Net Income + | -$33.94 M | -$44.88 M | -$51.11 M | -$41.10 M | -$60.62 M | -$62.34 M |
| Net Profit Margin | -425.69% | -285.57% | -157.26% | -146.32% | -267.26% | -185.21% |
ARS Pharmaceuticals, Inc. Common Stock Financials Balance Sheet In USD
Quarterly
| Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|
| Share Capital | $10.00 K | $10.00 K | $10.00 K | $10.00 K | $10.00 K | $10.00 K |
| Reserve & Surplus | -$157.17 M | -$202.17 M | -$253.29 M | -$294.48 M | -$355.32 M | -$417.70 M |
| Non-Current Liabilities | $70.72 M | $75.55 M | $174.27 M | $174.25 M | $176.65 M | $176.12 M |
| Current Liabilities | $27.62 M | $45.60 M | $50.88 M | $39.15 M | $49.61 M | $60.86 M |
| Total Liabilities | $98.34 M | $121.15 M | $225.15 M | $213.39 M | $226.26 M | $236.98 M |
| Fixed Assets | $8.32 M | $14.05 M | $15.94 M | $16.92 M | $16.46 M | $15.98 M |
| Current Assets | $303.86 M | $281.44 M | $338.86 M | $284.90 M | $245.24 M | $211.51 M |
| Total Assets | $327.32 M | $313.47 M | $372.80 M | $327.65 M | $287.57 M | $249.50 M |
ARS Pharmaceuticals, Inc. Common Stock Cash Flow
Quarterly
| Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|
| Net Income | -$33.94 M | -$44.88 M | -$51.15 M | -$41.32 M | -$60.62 M | -$62.34 M |
| Operating Cash Flow | -$40.74 M | -$39.59 M | -$47.05 M | -$43.48 M | -$44.95 M | -$60.93 M |
| Investing Cash Flow | $29.06 M | $48.57 M | -$44.98 M | $24.11 M | $27.79 M | $41.57 M |
| Financing Cash Flow | $725.00 K | $2.70 M | $100.05 M | $1.13 M | $159.00 K | $3.20 M |
| Change in Cash | -$10.95 M | $11.68 M | $8.02 M | -$18.24 M | -$17.00 M | -$16.16 M |
ARS Pharmaceuticals, Inc. Common Stock Return Calculator
The ARS Pharmaceuticals, Inc. Common Stock stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.
Returns Estimator
Based on past performance of this fund
ENTER AMOUNT
$10,000
Select Duration
5Yrs
1 Yr5 Yrs
If you had invested $10,000 5 years ago, what would its value be today?$10,000
Invested Amount$10,000
Est. Returns$0
About ARS Pharmaceuticals, Inc. Common Stock
ARS Pharmaceuticals Inc is a biopharmaceutical company focused on the commercialization and development of neffy (currently identified in the European Union (EU) and United Kingdom (U.K.) by the trade name EURneffy and in China) for needle-free intranasal delivery of epinephrine for emergency treatment of Type I allergic reactions, including anaphylaxis. Neffy is a proprietary composition of epinephrine with an absorption enhancer called Intravail, which allows Neffy to safely provide intranasal delivery of epinephrine at a low dose within the exposures of approved injectable products across a range of dosing conditions.
Popular Stocks
FAQs
What is the share price of ARS Pharmaceuticals, Inc. Common Stock today?
ARS Pharmaceuticals, Inc. Common Stock (SPRY) share price as of September 18, 2026 is $4.12. If you are investing from India, you can always check the valuation in the INR before investing.
Can Indian Investors purchase shares of ARS Pharmaceuticals, Inc. Common Stock?
Yes, Indian Investors can invest in the ARS Pharmaceuticals, Inc. Common Stock (SPRY) Share by opening an international trading account with Angel One.
How can I purchase ARS Pharmaceuticals, Inc. Common Stock shares in India?
Purchasing ARS Pharmaceuticals, Inc. Common Stock (SPRY) share from India can be done by: Directly: By opening an international trading account with Angel One. The process would include KYC verification. The account activation takes a few minutes to a few hours, after which you can start buying ARS Pharmaceuticals, Inc. Common Stock (SPRY) by making deposits in US dollars. Indirectly: By investing in mutual funds and Exchange Traded Funds (ETF) that offers exposure in global stocks.
Can I buy Fractional shares of ARS Pharmaceuticals, Inc. Common Stock?
Yes, you can purchase fractional shares of ARS Pharmaceuticals, Inc. Common Stock (SPRY) or any other US company shares in Angel One for any dollar amount.
What is the market capitalization value of ARS Pharmaceuticals, Inc. Common Stock?
The market capitalization of ARS Pharmaceuticals, Inc. Common Stock on September 18, 2026, is $414.20 M.
In which sector ARS Pharmaceuticals, Inc. Common Stock belongs?
ARS Pharmaceuticals, Inc. Common Stock operates in the Healthcare sector, specifically in the Healthcare industry.
What documents are required to invest in ARS Pharmaceuticals, Inc. Common Stock stocks?
In order to invest in ARS Pharmaceuticals, Inc. Common Stock (SPRY) you will need Proof of Identification (Aadhaar, PAN, Passport etc.) and Proof of Address (Aadhaar, Voter Card etc.). From start to end, the process is digital and can be seamless.
Diversify Your Portfolio with US Stocks
Invest in Wall Street Giants from India
